Newsletters - July 1998

A renowned Ayurvedic practitioner, Vaidya Balendu Prakash, honorary physician to the President of India, is quoted in a recent article in The Times of India, as having serious reservations about the misuse of traditional Ayurvedic formulations. Chyavanprash is a well known Ayurvedic product, described as a tonic for general well being. It traditionally contains Amla (Emblica officinalis) as a major ingredient and is valued for its vitamin C and calcium content. In recent years however, the unchecked commercialization of this product has introduced certain hazards. The high sugar content in the commercial products (65%, as a substitute for amla) may be harmful to diabetics, yet the labels carry no contraindications or any indications of actual ingredient levels. Unwary consumers continue to patronize these products under the belief that herbal products cause no untoward side effects.

The physician also questions "herbal" cosmetic formulations which often contain more than 90% chemicals and only 10% herbs. These concerns have universal relevance and accentuate the need for stringent quality control and labeling regulations. Such measures would help build a healthy image for herbal products world wide.

    HEADQUARTERS

  • Unit no.1200, 2nd Floor,
    Citiview Building
    12 Mac Dinh Chi Street
    Dakao Ward, District 1
    Hochiminh City 700000
    Vietnam

  • +84(28) 3930 0341
  • +84(28) 3930 0342
  • info@sabinsa.vn

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.